2009-08-01
Smad3 is a key nonredundant mediator of transforming growth factor β signaling in Nme mouse mammary epithelial cells
Publication
Publication
Molecular Cancer Research , Volume 7 - Issue 8 p. 1342- 1353
Smad2 and Smad3 are intracellular mediators of transforming growth factor β (TGFβ) signaling that share various biochemical properties, but data emerging from functional analyses in several cell types indicate that these two Smad proteins may convey distinct cellular responses. Therefore, we have investigated the individual roles of Smad2 and Smad3 in mediating the cytostatic and proapoptotic effects of TGFβ as well as their function in epithelial-to-mesenchymal transition. For this purpose, we transiently depleted mouse mammary epithelial cells (Nme) of Smad2 and/or Smad3 mainly by a strategy relying on RNaseH-induced degradation of mRNA. The effect of such depletion on hallmark events of TGFβ-driven epithelial-to-mesenchymal transition was analyzed, including dissolution of epithelial junctions, formation of stress fibers and focal adhesions, activation of metalloproteinases, and transcriptional regulation of acknowledged target genes. Furthermore, we investigated the effect of Smad2 and Smad3 knockdown on the TGFβ-regulated transcriptome by microarray analysis. Our results identify Smad3 as a key factor to trigger TGFβ-regulated events and ascribe tumor suppressor as well as oncogenic activities to this protein. Copyright
Additional Metadata | |
---|---|
doi.org/10.1158/1541-7786.MCR-08-0558, hdl.handle.net/1765/25271 | |
Molecular Cancer Research | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Dzwonek, J., Preobrazhenska, O., Cazzola, S., Conidi, A., Schellens, A., van Dinther, M., … Verschueren, K. (2009). Smad3 is a key nonredundant mediator of transforming growth factor β signaling in Nme mouse mammary epithelial cells. Molecular Cancer Research, 7(8), 1342–1353. doi:10.1158/1541-7786.MCR-08-0558 |